SC
BFRI icon

Scotia Capital’s Biofrontera BFRI Stock Holding History

Scotia Capital’s Portfolio BFRI Stock Details BFRI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-25,000
Closed -$27.3K – 855
2024
Q4 		$27.3K Sell
25,000
-25,000
-50% -$23.6K ﹤0.01% 840
2024
Q3 		$66.5K Sell
50,000
-70,000
-58% -$80.1K ﹤0.01% 811
2024
Q2 		$108K Buy
120,000
+80,000
+200% +$111K ﹤0.01% 795
2024
Q1 		$61.6K Buy
+40,000
New +$55.5K ﹤0.01% 806

Other funds holding BFRI

ACM
AIGH Capital Management Baltimore, Maryland $733M AUM 327.32% 1-Year Est. Return
RA
Rosalind Advisors Toronto, Ontario, Canada $249M AUM 80.12% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
VF
Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return
TSS
Two Sigma Securities New York $861M AUM 21.33% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
SS
SBI Securities Tokyo, Japan $4.4B AUM 74.25% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Scotia Capital's BFRI Position: Q1 2025 in Review

Scotia Capital sold out of Biofrontera (BFRI) in Q1 2025, closing a stake of 25,000 shares — an estimated $27.3K sold.

Scotia Capital first reported a position in BFRI in Q1 2024 and held it in 4 quarters. The position peaked at $108K in Q2 2024. 12 funds tracked by Wall St. Rank hold BFRI as of Q1 2025.

  • Scotia Capital reported no remaining Biofrontera position as of Q1 2025 after selling out during the quarter.
  • Scotia Capital sold 25,000 Biofrontera shares in Q1 2025, an estimated $27.3K.
  • Scotia Capital first reported a position in Biofrontera in Q1 2024 and held it in 4 quarters.
  • Scotia Capital's Biofrontera position peaked at $108K in Q2 2024.
  • 12 funds tracked by Wall St. Rank held Biofrontera as of Q1 2025.

Based on Scotia Capital's 13F filing for Q1 2025, filed 9 May 2025.